198 related articles for article (PubMed ID: 26149988)
21. Binding of Clostridium difficile toxins to human milk oligosaccharides.
El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
23. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
[TBL] [Abstract][Full Text] [Related]
24. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.
McKee RW; Mangalea MR; Purcell EB; Borchardt EK; Tamayo R
J Bacteriol; 2013 Nov; 195(22):5174-85. PubMed ID: 24039264
[TBL] [Abstract][Full Text] [Related]
25. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
[TBL] [Abstract][Full Text] [Related]
26. Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.
Kordus SL; Kroh HK; Rodríguez RC; Shrem RA; Peritore-Galve FC; Shupe JA; Wadzinski BE; Lacy DB; Spiller BW
PLoS Pathog; 2023 Oct; 19(10):e1011496. PubMed ID: 37871122
[TBL] [Abstract][Full Text] [Related]
27. [Profile of toxigenicity of Clostridium difficile strains isolated from paediatric patients with clinical diagnosis of antibiotic associated diarrhea (AAD)].
Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2005; 57(4):377-82. PubMed ID: 16773831
[TBL] [Abstract][Full Text] [Related]
28. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile.
Hundsberger T; Braun V; Weidmann M; Leukel P; Sauerborn M; von Eichel-Streiber C
Eur J Biochem; 1997 Mar; 244(3):735-42. PubMed ID: 9108241
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
Ho JG; Greco A; Rupnik M; Ng KK
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
[TBL] [Abstract][Full Text] [Related]
30. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
31. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
[TBL] [Abstract][Full Text] [Related]
32. Preliminary molecular analysis of Clostridium difficile isolates from healthy horses in northern Italy.
Ossiprandi MC; Buttrini M; Bottarelli E; Zerbini L
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e25-9. PubMed ID: 20004974
[TBL] [Abstract][Full Text] [Related]
33. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
Antunes A; Dupuy B
Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
[TBL] [Abstract][Full Text] [Related]
34. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
Edwards AN; Anjuwon-Foster BR; McBride SM
mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
[No Abstract] [Full Text] [Related]
35. The enterotoxicity of Clostridium difficile toxins.
Sun X; Savidge T; Feng H
Toxins (Basel); 2010 Jul; 2(7):1848-80. PubMed ID: 22069662
[TBL] [Abstract][Full Text] [Related]
36. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.
Rupnik M; Braun V; Soehn F; Janc M; Hofstetter M; Laufenberg-Feldmann R; von Eichel-Streiber C
FEMS Microbiol Lett; 1997 Mar; 148(2):197-202. PubMed ID: 9084148
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
Rupnik M
FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
[TBL] [Abstract][Full Text] [Related]
38. A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.
Wang YK; Yan YX; Kim HB; Ju X; Zhao S; Zhang K; Tzipori S; Sun X
Hum Vaccin Immunother; 2015; 11(9):2215-22. PubMed ID: 26036797
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
Dupuy B; Govind R; Antunes A; Matamouros S
J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.
Murase T; Eugenio L; Schorr M; Hussack G; Tanha J; Kitova EN; Klassen JS; Ng KK
J Biol Chem; 2014 Jan; 289(4):2331-43. PubMed ID: 24311789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]